Skip to main content
UNION KOREA PHARM CO.,Ltd logo

UNION KOREA PHARM CO.,Ltd — Investor Relations & Filings

Ticker · 080720 ISIN · KR7080720006 KO Manufacturing
Filings indexed 429 across all filing types
Latest filing 2025-09-01 Legal Proceedings Report
Country KR South Korea
Listing KO 080720

About UNION KOREA PHARM CO.,Ltd

https://ukp.co.kr/

UNION KOREA PHARM CO.,Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and distribution of prescription drugs. The company produces a range of specialty medicines in various formulations, including solid dosage forms, liquid injections, and powders. Its product portfolio addresses therapeutic areas such as neoplasms, immune system diseases, anti-inflammatory analgesics, antibiotics, and skeletal muscle relaxants. The company emphasizes strict quality control throughout the entire production cycle, from raw materials to shipping, to ensure its products meet Good Manufacturing Practice (GMP) standards. It operates in both domestic and international markets.

Recent filings

Filing Released Lang Actions
횡령ㆍ배임혐의진행사항
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure regarding the status of legal proceedings (embezzlement and breach of trust allegations) involving former directors of the company. It details the specific charges, the parties involved, the financial impact, and the current status (non-prosecution/no charges). This falls under the category of legal proceedings and regulatory updates.
2025-09-01 Korean
횡령ㆍ배임혐의진행사항
Legal Proceedings Report Classification · 100% confidence The document is a regulatory disclosure regarding the status of legal proceedings (embezzlement and breach of trust charges) involving former company executives. It details the investigation status, the specific charges, and the outcome (non-prosecution). This type of disclosure regarding legal matters and regulatory updates fits best under the 'Legal Proceedings Report' category.
2025-08-29 Korean
횡령ㆍ배임혐의진행사항
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure regarding the status of legal proceedings (embezzlement and breach of trust allegations) involving former directors of the company. It details the specific legal charges, the parties involved, the financial impact, and the current status (non-prosecution). This falls under the category of legal proceedings and regulatory updates.
2025-08-29 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the 41st fiscal period (2nd quarter) of Korea Union Pharm Co., Ltd. It covers the period from January 1, 2025, to June 30, 2025. It contains detailed corporate information, financial reporting structure, and management disclosures, which are characteristic of an interim/quarterly financial report. It is not a mere announcement (RPA) or a certification (RNS), as it provides substantive company data. H1 2025
2025-08-13 Korean
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a 'Disclaimer of Opinion' (의견거절) on the semi-annual financial statements of Korea Union Pharmaceutical. It details financial distress indicators such as capital impairment (자본잠식률) and audit opinion status. Since this is a specific regulatory disclosure regarding audit findings and financial status rather than a full report or a simple announcement of a report's availability, it falls under the 'Regulatory Filings' category. H1 2025
2025-08-13 Korean
[기재정정]사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is a 'Correction Report' (정정신고) for an 'Annual Report' (사업보고서) for the 40th fiscal year of Korea Union Pharm Co., Ltd. It contains detailed corporate information, including board/management changes, shareholder meeting summaries, capital changes, and shareholding status. Since it is a comprehensive annual filing (10-K equivalent in the Korean market) that has been corrected, it is classified as an Annual Report. FY 2024
2025-08-11 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.